Background Haemostasis is crucial for the success of oral surgical treatment as bleeding problems can cause complications both pre- and post-operatively. Patients on anticoagulant drugs present a challenge due to their increased risk of bleeding.Aims To review the evidence for the management of oral surgery patients on novel oral anticoagulant therapy.Methods A literature review was conducted in May 2016 of free-text and MESH searches (keywords: apixaban, dabigatran, rivaroxaban and dental extractions) in the Cochrane Library, PubMed and CINAHL. Trial registers, professional bodies for guidelines and OpenGrey for unpublished literature were also searched. Studies were selected for appraisal after limits were applied (adult, human and English only studies) and inclusion/exclusion criteria imposed.Results Five studies were identified for critical appraisal using the CASP tools. These were a combination of systematic reviews and case series. Two case series were excluded due to low quality evidence. Curtin et al., Davis et al. and Constantinides et al. together with guidelines from the Scottish Dental Clinical Effectiveness Programme, have highlighted a protocol in managing these patients in a dental surgical setting.Conclusion Patients on novel anticoagulant therapy requiring dental surgery can be managed appropriately either without discontinuation of therapy or a delay in dose. For those patients at higher risks of postoperative bleeding complications, it is advised to liaise with the specialist physician.

Aim Coronavirus disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), originated in December 2019 from Wuhan, China. This virus has spread worldwide, with over 16 million cases and over 650,000 deaths. The novel coronavirus disease (COVID‐19) has resulted in significant impact on the livelihoods of the British public and has had implications for healthcare delivery. The cancellation of elective procedures is likely to affect Oral Surgery specialty training. This paper aims to ascertain the extent of any impact of COVID‐19 on Oral Surgery specialty training. Material and Methods A survey was created for Oral Surgery specialty trainees in the UK. A variety of questions were used, including multiple choice, yes/no, Likert scales and free text answers. All questions were related to the impact of COVID‐19 on training. Results A total of 34 full responses were recorded. Results showed that COVID‐19 has had an immense impact on Oral Surgery training, with most trainees recording high anxiety levels regarding the future of their training. The overall experience of most trainees involved a reduction in logbook procedures, cancelled study days, courses or conferences. Conclusion Though oral surgery training has been deficient during this period, some trainees reported positive experiences while redeployed in other fields or specialties. In addition, we highlight the significant effect on trainees’ mental health. Most trainees suggested a training period extension to remedy deficiencies. From this paper, we identify the wide‐ranging effects of the pandemic, and Oral Surgery trainees now await decisions on the future of specialty training.

With high levels of anxiety among trainees, those with responsibility for training must enable a fair and flexible approach to assessment.

Background:The potential oral health effects of electronic cigarettes has received very little attention. Methods: We conducted a systematic review of the literature from 2010 to 2016 to establish if there was any evidence for oral health effects from e-cigarette usage. Results: Different advice given by different authorities and countries was found. We discuss in our presentation the results of this literature. Discussion: More research in this field is required to examine the long-term safety of electronic cigarettes use. All oral health care professionals need to be cautious with the advice given to patients until definitive guidelines exist.